DOHealthpeak Properties statistics
$19.98−0.70%Close 13 Nov 2026 · Market value $13.58B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Healthpeak Properties is valued at $13.58B on its latest close. Its price is 36.0 times its earnings.
| Market value | $13.58B |
|---|
| Enterprise value | $25.87B |
|---|
| Price / earnings | 36.00 |
|---|
| Price / sales | 4.43 |
|---|
| Price / book | 1.73 |
|---|
| EV / EBITDA | 20.59 |
|---|
| EV / sales | 8.44 |
|---|
| Price / free cash flow | 30.10 |
|---|
| Price / free cash flow, own 5-year average | 164.52 |
|---|
| EV / EBIT | 185.79 |
|---|
| EV / free cash flow | 50.40 |
|---|
| Free cash flow yield | 3.3% |
|---|
| Dividend yield | 6.2% |
|---|
Share price
| Latest close | $19.98 |
|---|
| Day's change | −0.7% |
|---|
| 52-week high | $22.95 |
|---|
| 52-week low | $15.70 |
|---|
| From 52-week high | −12.9% |
|---|
| Return · 1 month | +5.3% |
|---|
| Return · 3 months | −5.8% |
|---|
| Return · year to date | +24.3% |
|---|
| Return · 1 year | +13.3% |
|---|
| Beta · 1 year against the S&P 500 | 0.36 |
|---|
| 50-day average | $19.68 |
|---|
| 200-day average | $19.25 |
|---|
| RSI 14 | 54.2 |
|---|
| Average volume · 20 sessions | 6.2M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 7.6% |
|---|
| Net margin | 2.5% |
|---|
| Free cash flow margin | 12.6% |
|---|
| Return on equity | 0.9% |
|---|
| Return on assets | 1.0% |
|---|
| Return on invested capital | 1.0% |
|---|
| Return on invested capital, 5-year average | 0.8% |
|---|
| Stock-based compensation / revenue | 0.5% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $467.5M |
|---|
| Total debt | $10.14B |
|---|
| Net debt | $9.68B |
|---|
| Debt / equity | 1.35 |
|---|
| Net debt / EBITDA | 7.60 |
|---|
| Interest coverage | 0.70 |
|---|
Growth
| Revenue, latest quarter on a year | +16.3% |
|---|
| Revenue, twelve months on a year | +9.4% |
|---|
| Revenue, 5-year compound | +11.4% |
|---|
| Revenue, 10-year compound | +3.8% |
|---|
| Net income, 5-year compound | −29.6% |
|---|
| EPS, 5-year compound | −33.4% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 696M |
|---|
| Shares outstanding, 5-year compound | +5.6% |
|---|
| Net share repurchases | $97.14M |
|---|
| Dividends per share | $1.22 |
|---|
| Dividend payout | 1190% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $9.28M |
|---|
| Effective tax rate | 3.3% |
|---|
DOC in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.